Works by Wang, Shirley V.


Results: 82
    1
    2

    The Oncology QCARD Initiative: Fostering efficient evaluation of initial real‐world data proposals.

    Published in:
    Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 11, p. 1, doi. 10.1002/pds.5818
    By:
    • Rivera, Donna R.;
    • Eckert, Joy C.;
    • Rodriguez‐Watson, Carla;
    • Lerro, Catherine C.;
    • Bertagnolli, Monica M.;
    • Hubbard, Rebecca A.;
    • Kushi, Lawrence H.;
    • Lund, Jennifer L.;
    • Schrag, Deborah;
    • Wang, Shirley V.;
    • Wood, William A.;
    • Lee, Jennifer J.;
    • Okafor, Cristeen;
    • Ghauri, Kanwal;
    • Winckler, Susan C.;
    • Kluetz, Paul G.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10

    HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real‐world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.

    Published in:
    Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 1, p. 44, doi. 10.1002/pds.5507
    By:
    • Wang, Shirley V.;
    • Pottegård, Anton;
    • Crown, William;
    • Arlett, Peter;
    • Ashcroft, Darren M.;
    • Benchimol, Eric I.;
    • Berger, Marc L.;
    • Crane, Gracy;
    • Goettsch, Wim;
    • Hua, Wei;
    • Kabadi, Shaum;
    • Kern, David M.;
    • Kurz, Xavier;
    • Langan, Sinead;
    • Nonaka, Takahiro;
    • Orsini, Lucinda;
    • Perez‐Gutthann, Susana;
    • Pinheiro, Simone;
    • Pratt, Nicole;
    • Schneeweiss, Sebastian
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    The Aetion Coalition to Advance Real‐World Evidence through Randomized Controlled Trial Emulation Initiative: Oncology.

    Published in:
    Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1217, doi. 10.1002/cpt.2800
    By:
    • Merola, David;
    • Campbell, Ulka;
    • Gautam, Nileesa;
    • Rubens, Alexa;
    • Schneeweiss, Sebastian;
    • Wang, Shirley V.;
    • Carrigan, Gillis;
    • Chia, Victoria;
    • Ovbiosa, Osayi E.;
    • Pinheiro, Simone;
    • Bruno, Amanda;
    • Jiao, Xiaolong;
    • Stewart, Mark;
    • Hendricks‐Sturrup, Rachele;
    • Rodriguez‐Watson, Carla;
    • Khosla, Sajan;
    • Zhang, Yiduo;
    • Rimawi, Mothaffar;
    • Huang, Jenny;
    • Taylor, Aliki
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38

    A General Propensity Score for Signal Identification Using Tree-Based Scan Statistics.

    Published in:
    American Journal of Epidemiology, 2021, v. 190, n. 7, p. 1424, doi. 10.1093/aje/kwab034
    By:
    • Wang, Shirley V;
    • Maro, Judith C;
    • Gagne, Joshua J;
    • Patorno, Elisabetta;
    • Kattinakere, Sushama;
    • Stojanovic, Danijela;
    • Eworuke, Efe;
    • Baro, Elande;
    • Ouellet-Hellstrom, Rita;
    • Nguyen, Michael;
    • Ma, Yong;
    • Dashevsky, Inna;
    • Cole, David;
    • DeLuccia, Sandra;
    • Hansbury, Aaron;
    • Pestine, Ella;
    • Kulldorff, Martin
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32310-3
    By:
    • Wang, Shirley V.;
    • Sreedhara, Sushama Kattinakere;
    • Schneeweiss, Sebastian;
    • REPEAT Initiative;
    • Franklin, Jessica M.;
    • Gagne, Joshua J.;
    • Huybrechts, Krista F.;
    • Patorno, Elisabetta;
    • Jin, Yinzhu;
    • Lee, Moa;
    • Mahesri, Mufaddal;
    • Pawar, Ajinkya;
    • Barberio, Julie;
    • Bessette, Lily G.;
    • Chin, Kristyn;
    • Gautam, Nileesa;
    • Ortiz, Adrian Santiago;
    • Sears, Ellen;
    • Stefanini, Kristina;
    • Zakarian, Mimi
    Publication type:
    Article
    48
    49

    Improving transparency to build trust in real‐world secondary data studies for hypothesis testing—Why, what, and how: recommendations and a road map from the real‐world evidence transparency initiative.

    Published in:
    Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1504, doi. 10.1002/pds.5079
    By:
    • Orsini, Lucinda S.;
    • Monz, Brigitta;
    • Mullins, C. Daniel;
    • Van Brunt, David;
    • Daniel, Gregory;
    • Eichler, Hans‐Georg;
    • Graff, Jennifer;
    • Guerino, John;
    • Berger, Marc;
    • Lederer, Nirosha M.;
    • Jonsson, Pall;
    • Schneeweiss, Sebastian;
    • Wang, Shirley V.;
    • Crown, William;
    • Goettsch, Wim;
    • Willke, Richard J.
    Publication type:
    Article
    50